Ancient Fables for the Neobiological Age
By Brian Bergstein,
Neo.Life
| 12. 28. 2017
What “Frankenstein” and the golem tell us about the power and responsibility of science.
January 1 marks the 200th anniversary of the publication of Frankenstein, Mary Shelley’s remarkable novel about a scientist who cobbles together body parts and brings them to life in a “new species.” Because Victor Frankenstein’s project has terrible unintended consequences — he ditches his monster because it is ugly, and the creature roams the world in a destructive search for a mate — the novel can be read as a warning about messing with nature. Those sad and scary themes rear up when people use a term like “Frankenfoods” to denigrate bioengineered products.
But even if Shelley thought of the book as cautionary tale (and it’s debatablewhether she did), that isn’t a very useful cultural shorthand today, as we wrestle with the implications of gene editing, gene writing, and other technologies that give us more power than ever to manipulate biology. Caution is of course required with these technologies. But an excess of it—too much worry about unleashing Frankenstein’s monster—could be even more dangerous. Ultimately, we’re going to have...
Related Articles
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Sayantani DasGupta, MedPage Today | 08.05.2025
It's just a jeans ad.
It's not that deep.
It's just social media outrage.
Should physicians care about the recent American Eagle "Sydney Sweeney Has Good Genes Jeans" controversy? What, if anything, does the provocative campaign have to...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...